Utilizing Ceftazidime/Avibactam Therapeutic Drug Monitoring in the Treatment of Neurosurgical Meningitis Caused by Difficult-to-Treat Resistant Pseudomonas aeruginosa and KPC-Producing Enterobacterales

Author:

Yasmin Mohamad1ORCID,Nutman Amir2ORCID,Wang Lu3,Marshall Steven1,Chen Ke3,Wang Jiping3,Yahav Dafna2ORCID,Lupinsky Liad4,Hujer Andrea M5,Bhimraj Adarsh6,van Duin David7ORCID,Li Jian3,Bonomo Robert A158910

Affiliation:

1. Louis Stokes Cleveland Department of Veterans Affairs Medical Center , Cleveland, Ohio , USA {C}%3C!%2D%2D%7BC%7D%253C!%252D%252D%257BC%257D%25253C!%25252D%25252D%25257C%25257CrmComment%25257C%25257C%25253C~show%252520%25255BAQ%252520ID%25253DAQ12%25255D~%25253E%25252D%25252D%25253E%252D%252D%253E%2D%2D%3E

2. Infectious Diseases Unit, Rabin Medical Center, Beilinson Campus, Petah Tiqva and Sackler Faculty of Medicine, Tel-Aviv University , Tel-Aviv , Israel

3. Biomedicine Discovery Institute, Monash University , Melbourne, Victoria , Australia

4. Neurosurgical Department, Rabin Medical Center, Beilinson Campus , Petah Tiqva , Israel

5. Department of Medicine, Case Western Reserve University School of Medicine , Cleveland, Ohio , USA

6. Division of Infectious Diseases, Houston Methodist Hospital , Houston, Texas , USA

7. Department of Medicine, University of North Carolina , Chapel Hill, North Carolina , USA

8. Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine , Cleveland, Ohio , USA

9. CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES) , Cleveland, Ohio , USA

10. Departments of Proteomics and Bioinformatics, Pharmacology, and Biochemistry, Case Western Reserve University School of Medicine , Cleveland, Ohio , USA

Abstract

Abstract Background Central nervous system (CNS) infections caused by Klebsiella pneumoniae carbapenemase (KPC)–producing Enterobacterales and difficult-to-treat resistant (DTR) Pseudomonas aeruginosa represent a formidable clinical challenge. Antimicrobial regimens that efficiently penetrate the cerebrospinal fluid (CSF) and achieve sufficient concentrations associated with microbiologic and clinical cure are limited. We evaluated therapy with ceftazidime-avibactam (CAZ-AVI) in order to guide precise dosing in the treatment of CNS infections. Methods Therapeutic drug monitoring (TDM) was performed in 3 patients with health care–associated ventriculitis and meningitis (HAVM) using CAZ-AVI 2.5 g infused intravenously every 8 hours as standard and extended infusion. Simultaneous CSF and plasma samples were obtained throughout the dosing interval in each patient. Concentrations of CAZ and AVI were determined by liquid chromatography/mass spectrometry. Results Bacterial identification revealed KPC-producing Klebsiella pneumoniae (KPC-Kp), DTR Pseudomonas aeruginosa, and KPC-producing Enterobacter cloacae (KPC-Ent.c). All isolates were resistant to carbapenems. The minimum inhibitory concentrations (MICs) of CAZ-AVI were 0.25/4, 4/4, and 0.25/4 μg/mL, respectively. CAZ and AVI concentrations were determined in CSF samples ranging from 29.0 to 15.0 µg/mL (CAZ component) and 4.20 to 0.92 µg/mL (AVI component), respectively. AVI achieved concentrations ≥1 µg/mL in 11 out of 12 CSF samples collected throughout the dosing interval. Clinical and microbiologic cure were attained in all patients. Conclusions Postinfusion concentrations of CAZ-AVI were measured in plasma and CSF samples obtained from 3 patients with complicated CNS infections caused by antimicrobial-resistant isolates. The measured concentrations revealed that standard CAZ and AVI exposures sufficiently attained values correlating to 50% fT > MIC, which are associated with efficient bacterial killing.

Funder

National Institute of Allergy and Infectious Diseases of the National Institutes of Health

Cleveland Department of Veterans Affairs

Biomedical Laboratory Research & Development Service of the VA Office of Research and Development

Geriatric Research Education and Clinical Center VISN 10

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Reference22 articles.

1. Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections;Nau;Curr Opin Infect Dis,2018

2. Clinical pharmacokinetics of antibacterials in cerebrospinal fluid;Di Paolo;Clin pharmacokinet,2013

3. Clinical data from studies involving novel antibiotics to treat multidrug-resistant gram-negative bacterial infections;Kanj;Int J Antimicrob Agents,2022

4. Old and new beta-lactamase inhibitors: molecular structure, mechanism of action, and clinical use;Carcione;Antibiotics,2021

5. Pharmacokinetics of the new β-lactamase inhibitor NXL104 in an experimental rabbit meningitis model: restoration of the bacteriological efficacy of ceftazidime (CAZ) against a class C producing K pneumoniae;Cottagnoud,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3